A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome

Poly(amidoamine) Dendrimers with Carbonic Anhydrase Inhibitory Activity and Antiglaucoma Action

(2015) Fabrizio Carta et al.   JOURNAL OF MEDICINAL CHEMISTRY

Matrix Metalloproteinase 9 and Transglutaminase 2 Expression at the Ocular Surface in Patients with Different Forms of Dry Eye Disease

(2015) Pasquale Aragona et al.   OPHTHALMOLOGY

Dynamic Ocular Surface and Lacrimal Gland Changes Induced in Experimental Murine Dry Eye

(2015) Bing Xiao et al.   PLoS One

Dendrimers: synthesis, applications, and properties

(2014) Elham Abbasi et al.   Nanoscale Research Letters

Carbonic anhydrase inhibitors: an editorial

(2013) Claudiu T Supuran   EXPERT OPINION ON THERAPEUTIC PATENTS

Antiglaucoma carbonic anhydrase inhibitors: a patent review

(2013) Emanuela Masini et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Antiobesity carbonic anhydrase inhibitors: a literature and patent review

(2013) Andrea Scozzafava et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013)

(2013) Fabrizio Carta et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Topical delivery of ocular therapeutics: carrier systems and physical methods

(2013) Joel G. Souza et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases

(2012) Jean-Yves Winum et al.   CHEMICAL COMMUNICATIONS

Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors

(2012) Anna Di Fiore et al.   CHEMICAL COMMUNICATIONS

A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology

(2011) Francesca Fabrizi et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs)

(2010) Emanuele Attolino et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Interdomain Flexibility in Full-length Matrix Metalloproteinase-1 (MMP-1)

(2009) Ivano Bertini et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Deciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins

(2009) Alfonso Maresca et al.   JOURNAL OF MEDICINAL CHEMISTRY

Non-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors#

(2009) Alfonso Maresca et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IL-17 disrupts corneal barrier following desiccating stress

(2009) C S De Paiva et al.   Mucosal Immunology

Nanotechnology in ocular drug delivery

(2008) S SAHOO et al.   DRUG DISCOVERY TODAY

Application of dendrimer–drug complexation in the enhancement of drug solubility and bioavailability

(2008) Narendra K Jain et al.   Expert Opinion on Drug Metabolism & Toxicology

Evidence of Reciprocal Reorientation of the Catalytic and Hemopexin-Like Domains of Full-Length MMP-12

(2008) Ivano Bertini et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

(2008) Claudiu T. Supuran   NATURE REVIEWS DRUG DISCOVERY